HOME PAGE ABOUT US CONTACT US SUBSCRIBE ADVERTISE ARCHIVES
TOP STORIES NATION ECONOMY COMPANIES SHIPPING OPINION PERSPECTIVE LIFE SPORTS MOTORING
SEARCH ENGINE
WWWOur Site
Anchored by Jonathan dela Cruz, Salvador Escudero, Boying Remulla, Teddy Boy Locsin and Alvin Capino
Monday to Friday
8:00pm-10:00pm

ARTICLE SERVICES
  • bookmark this page
  • print this article
  • view archive
  •  
    Rice-based cholera vaccine developed in Japan
     
    By Amber Dance
    Los Angeles Times
     

    Japanese researchers have developed a genetically engineered rice that protects against cholera, offering the hope of an inexpensive, easily stored vaccine that could make a major impact against diseases in third-world countries.

    The research, carried out by Hiroshi Kiyono and colleagues at the University of Tokyo, was published online in the Proceedings of the National Academy of Sciences.

    The scientists engineered the rice to produce a portion of the cholera toxin protein in the grains. Mice that ate the powdered rice did not get sick when later fed complete cholera toxin.

    Injected vaccines are not typically effective for diseases of the digestive system, such as cholera. Kiyono and his coauthors designed their vaccine to target mucous membranes such as the nose and mouth, where over 90 percent of infectious agents enter the body. This new system for making vaccines, dubbed MucoRice, could potentially be used for several diseases, such as anthrax and the flu.

    Scientists have been working on plant-based vaccines since 1990, using plants such as tobacco, potatoes and corn.

    However, food-based vaccines are tricky because the vaccine may cause an allergic reaction to the food, or it may be digested too quickly to stimulate an immune response.

    “This is the first time anyone has used rice,” said Charles Arntzen, a plant biotechnologist at Arizona State University. “Rice is particularly useful because it is a well-tolerated food crop and it is digested slowly.”

    Kiyono and his colleagues found that their rice-based vaccine did not cause an immune response to rice proteins and was digested slowly enough to allow immunity to develop.

    Most vaccines must stay cold during both storage and transport, which makes delivery to developing nations expensive. The cost to keep vaccines chilled is estimated at $200-300 million each year.

    The rice-based cholera vaccine, in contrast, was still effective after over a year stored at room temperature.

    Such a vaccine would be needle- and pain-free, probably available as a tablet or capsule containing powdered rice. This would diminish the accumulation of needles as medical waste.

    OTHER STORIES

    Rice-based cholera vaccine developed in Japan

    Japanese researchers have developed a genetically engineered rice that protects against cholera, offering the hope of an inexpensive, easily stored vaccine that could make a major impact against diseases in third-world countries.

    read more

    Higher pay urged to lure math, science teachers

    WASHINGTON—Higher starting salaries, more rigorous teacher-training programs and additional support for first year teachers are just a few of the incentives needed to deal with a projected shortfall of more than 280,000 math and science teachers across the country by 2015, according to a group of business, foundation and higher education leaders.

    read more

    Finger length predicts SAT performance

    A quick look at the lengths of children’s index and ring fingers can be used to predict how well students will perform on Scholastic Asessment Tests (SATs), new research claims.

    read more

    Surgeons to operate on patient with drug-resistant TB

    Denver surgeons said they will remove a tennis ball-sized section of lung from Atlanta attorney Andrew Speaker, the air traveler who set off a worldwide scare when it was revealed that he carries an extremely drug-resistant form of tuberculosis.

    read more